Contemporary Trends in Adjuvant and Neoadjuvant Treatment for Renal Cell Carcinoma
Journal Title: Üroonkoloji Bülteni - Year 2018, Vol 17, Issue 3
Abstract
Renal cell carcinoma is an increasingly significant cancer in which surgical resection is still the sole curative approach. There is a risk of recurrence in one-third of patients after surgery. Successful experiences with some solid organ cancers and effective treatment response to targeted agents in metastatic cases have suggested a similar adjuvant approach for renal cell carcinoma. Consequently, placebo-controlled adjuvant trials have been reported and the Food and Drug Administration approved sunutinib as an adjuvant treatment after nephrectomy in high-risk patients, with the risk of treatment-related side effects. Several clinical series have indicated that neoadjuvant application can provide significant downsizing of the cancer mass in complex cases and enable radical surgery. Similarly, neoadjuvant therapy could enable nephron-sparing surgery for certain patients. Both adjuvant and neoadjuvant approaches for renal cell carcinoma require further trials with larger patient numbers. This review presents contemporary experience on adjuvant and neoadjuvant treatment for renal cell carcinoma.
Authors and Affiliations
Kamil Çam
Keywords
Related Articles
- EP ID EP382524
- DOI 10.4274/uob.1030
- Views 104
- Downloads 0
Evaluation of Prostatic Artery Embolization Efficiency in Benign Prostatic Hyperplasia Patients with High Comorbidity
Objective: The purpose of this study was to evaluate efficacy outcomes following prostate artery embolization (PAE) for the treatment of benign prostatic hyperplasia (BPH) patients with high comorbidity. Materials and M...
Renal Function Deterioration After Radical Cystectomy and Analysis of Predictive Factors for Renal Deterioration
Objective: Renal function deterioration develops in most of the patients treated with radical cystectomy (RC). In this study, we aimed to evaluate the changes in renal function of bladder cancer (BC) patients who had min...
A Rare Tumor: Prostate Neuroendocrine Carcinoma Case Report
Neuroendocrine prostate cancer is very rare disease with high mortality. It is one of the most commonly observed extrapulmonary small cell lung cancer types. In this case report we wanted to indicate how aggressive can n...
Long-Term Outcomes of Patients Who Underwent Ureterocutaneostomy
Objective: Ureterocutaneostomy (UCS) is a urinary diversion (UD) method which is used rarely in a carefully selected patient group. In this study, we aimed to present the data and long-term outcomes of patients who under...
Socioeconomic Predictors and Patient Perspectives of Prostate-specific Antigen Testing
Objective: To identify important factors affecting men’s decision to undergo prostate-specific antigen (PSA) testing and to determine who is at risk for prostate cancer based on age-specific PSA values. Materials and Me...